Sarker,R. (2022). Effectiveness of educational intervention on breast cancer knowledge and breast self-examination among female university students in Bangladesh: a pre-post quasi-experimental study. Bmc Cancer, 22(1), 199. https://doi.org/10.1186/s12885-022-09311-y

Article  PubMed  PubMed Central  Google Scholar 

Sung,H. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660

Article  CAS  Google Scholar 

Rugo,H. S. (2016). Endocrine therapy for hormone receptor–positive metastatic breast cancer: American Society of Clinical Oncology guideline. Journal of Clinical Oncology, 34(25), 3069–3103. https://doi.org/10.1200/JCO.2016.67.1487

Article  CAS  PubMed  Google Scholar 

Lancet, E. (2011). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. The Lancet, 378(9804), 1707–1716.

Article  Google Scholar 

Ali,S. (2016). Molecular mechanisms and mode of tamoxifen resistance in breast cancer. Bioinformation, 12(3), 135. https://doi.org/10.6026/97320630012135

Article  PubMed  PubMed Central  Google Scholar 

Shi,Y. (2021). Simultaneous detection of CA15-3 and PGRMC1 on a microfluidic chip for early diagnosis of breast cancer. Journal of Liquid Chromatography & Related Technologies, 44(11–12), 519–528. https://doi.org/10.1080/10826076.2021.1968896

Article  CAS  Google Scholar 

Zhao, Y., Pu, C., & Liu, Z. J. T. B. (2022). Essential amino acids deprivation is a potential strategy for breast cancer treatment. The Breast, 62: pp. 152–161 https://doi.org/10.1016/j.breast.2022.02.009

Mishra, A. (2021). Metabolic reprograming confers tamoxifen resistance in breast cancer. Chemico-Biological Interactions, 347, 109602. https://doi.org/10.1016/j.cbi.2021.109602

Lv,L. (2022). Relationship between metabolic reprogramming and drug resistance in breast cancer. Frontiers in Oncology, 12, 942064. https://doi.org/10.3389/fonc.2022.942064

Matsugami,T. R. (2006). Indispensability of the glutamate transporters GLAST and GLT1 to brain development. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 103(32), 12161–12166. https://doi.org/10.1073/pnas.0509144103

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhutia,Y. D. (2015). Amino acid transporters in cancer and their relevance to glutamine addiction: novel targets for the design of a new class of anticancer drugs. Cancer Research, 75(9), 1782–1788. https://doi.org/10.1158/0008-5472.CAN-14-3745

Article  CAS  PubMed  Google Scholar 

Yao,D. (2000). A novel system A isoform mediating Na+/neutral amino acid cotransport. The Journal of Biological Chemistry, 275(30), 22790–22797. https://doi.org/10.1074/jbc.M002965200

Article  CAS  PubMed  Google Scholar 

Jyotsana,N., & Ta, K. T. (2022). and K.E.J.F.i.o. DelGiorno, The role of cystine/glutamate antiporter SLC7A11/xCT in the pathophysiology of cancer.Frontiers in Oncology , 12, 858462. https://doi.org/10.3389/fonc.2022.858462

Kunicka,T. (2014). and P.J.D.m.r. Souček, Importance of ABCC1 for cancer therapy and prognosis. Drug Metabolism Reviews, 46(3), 325–342. https://doi.org/10.3109/03602532.2014.901348

Article  CAS  PubMed  Google Scholar 

Auberson,M. (2018). SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney. European Journal of Physiology, 470, 1739–1751. https://doi.org/10.1007/s00424-018-2190-4

Battelli,M. G. (2016). Xanthine oxidoreductase in cancer: more than a differentiation marker. Cancer Medicine, 5(3), 546–557. https://doi.org/10.1002/cam4.601

Article  CAS  PubMed  Google Scholar 

Kandasamy,P. (2018). Amino acid transporters revisited: New views in health and disease. Trends in Biochemical Sciences, 43(10), 752–789. https://doi.org/10.1016/j.tibs.2018.05.003

Article  CAS  PubMed  Google Scholar 

Alhusban,A. A. (2016). Capillary electrophoresis for automated on-line monitoring of suspension cultures: Correlating cell density, nutrients and metabolites in near real-time. Analytica Chimica Acta, 920, 94–101. https://doi.org/10.1016/j.aca.2016.03.034

Hempel,G. (2000). Strategies to improve the sensitivity in capillary electrophoresis for the analysis of drugs. in biological fluids Electrophoresis, 21(4), 691–698. https://pubmed.ncbi.nlm.nih.gov/10733208/

Article  CAS  PubMed  Google Scholar 

Rey-Stolle,F. (2022). Low and high resolution gas chromatography-mass spectrometry for untargeted metabolomics: A tutorial. Analytica Chimica Acta, 1210, 339043. https://doi.org/10.1016/j.aca.2021.339043

Sharifi,S. (2022). Mass spectrometry, structural analysis, and anti-inflammatory properties of photo-cross-linked human albumin hydrogels. ACS Applied Bio Materials, 5(6), 2643–2663. https://doi.org/10.1021/acsabm.2c00109

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamadneh,L. (2020). Upregulation of PI3K/AKT/PTEN pathway is correlated with glucose and glutamine metabolic dysfunction during tamoxifen resistance development in MCF-7 cells. Scientific Reports, 10(1), 21933. https://doi.org/10.1038/s41598-020-78833-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alhusban,A. A (2022). Lactate and pyruvate levels correlation with lactate dehydrogenase gene expression and glucose consumption in Tamoxifen-resistant MCF‐7 cells using capillary electrophoresis with contactless conductivity detection (CE‐C4D). Electrophoresis, 43(3), 446–455. https://doi.org/10.1002/elps.202100217

Alhusban,A. A. (2023). Rapid and sensitive HPLC–MS/MS method for the quantification of dopamine, GABA, serotonin, glutamine and glutamate in rat brain regions after exposure to tobacco cigarettes. Biomedical Chromatography, 37(1), e5513. https://doi.org/10.1002/bmc.5513

Article  CAS  PubMed  Google Scholar 

Agency, E. (2011). M.J.C.f.M.P.f.H.U., European Medicines Agency, Guideline on bioanalytical method validation.

Waks,A. G., & Winer, E. P. J. J. (2019). Breast cancer treatment: a review. Journal of the American Medical Association, 321(3), 288–300. https://doi.org/10.1001/jama.2018.19323

Article  CAS  PubMed  Google Scholar 

Kennedy,L. (2020). Role of glutathione in cancer: from mechanisms to therapies. Biomolecules, 10(10), 1429. https://doi.org/10.3390/biom10101429

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alwahsh,M. (2024). Glutathione and xanthine metabolic changes in tamoxifen resistant breast cancer cell lines are mediated by down-regulation of GSS and XDH and correlated to poor prognosis. Journal of Cancer, 15(13), 4047. https://doi.org/10.7150/jca.96659

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo,W. (2021). Dysregulated glutamate transporter SLC1A1 propels cystine uptake via xc – for glutathione synthesis in lung cancer. Cancer Research, 81(3), 552–566. https://doi.org/10.1158/0008-5472.CAN-20-0617

Article  CAS  PubMed  Google Scholar 

Han,X. (2019). Overexpression of uric acid transporter SLC2A9 inhibits proliferation of hepatocellular carcinoma cells. Oncology Research, 27(5), 533. https://doi.org/10.3727/096504018X15199489058224

Article  PubMed  Google Scholar